Found: 10
Select item for more details and to access through your institution.
Immune response to ART initiation in advanced HIV infection.
- Published in:
- HIV Medicine, 2023, v. 24, n. 6, p. 716, doi. 10.1111/hiv.13467
- By:
- Publication type:
- Article
Once-Daily versus Twice-Daily Lamivudine, in Combination with Zidovudine and Efavirenz, for the Treatment of Antiretroviral-Naive Adults with HIV Infection: A Randomized Equivalence Trial.
- Published in:
- Clinical Infectious Diseases, 2004, v. 39, n. 3, p. 411
- By:
- Publication type:
- Article
Improvement in Lipoatrophy Associated with Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus--Infected Patients Switched from Stavudine to Abacavir or Zidovudine: The Results of the TARHEEL Study.
- Published in:
- Clinical Infectious Diseases, 2004, v. 38, n. 2, p. 263
- By:
- Publication type:
- Article
Abacavir Expanded Access Program for Adult Patients Infected with Human Immunodeficiency Virus Type 1.
- Published in:
- Clinical Infectious Diseases, 2002, v. 34, n. 4, p. 535, doi. 10.1086/338638
- By:
- Publication type:
- Article
Challenges of Antiretroviral Treatment in Transient and Drug-Using Populations: The SUN Study.
- Published in:
- AIDS Patient Care & STDs, 2001, v. 15, n. 3, p. 129, doi. 10.1089/108729101750123580
- By:
- Publication type:
- Article
Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 12, p. 2807, doi. 10.1007/s40121-023-00890-2
- By:
- Publication type:
- Article
Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment.
- Published in:
- BMC Infectious Diseases, 2005, v. 5, n. 1, p. 2, doi. 10.1186/1471-2334-5-2
- By:
- Publication type:
- Article
Advanced HIV Infection in Treatment-Naïve Individuals: Effectiveness and Persistence of Recommended 3-Drug Regimens.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 3, p. 1, doi. 10.1093/ofid/ofac018
- By:
- Publication type:
- Article
Lipid Levels and Changes in Body Fat Distribution in Treatment-Naive, HIV-1–Infected Adults Treated With Rilpivirine or Efavirenz for 96 Weeks in the ECHO and THRIVE Trials.
- Published in:
- Clinical Infectious Diseases, 2014, v. 59, n. 3, p. 425
- By:
- Publication type:
- Article
Lipid Metabolism and Lipodystrophy in HIV-1-Infected Patients: The Role Played by Nonnucleoside Reverse Transcriptase Inhibitors.
- Published in:
- AIDS Reviews, 2015, v. 17, n. 1, p. 21
- By:
- Publication type:
- Article